StockClub

NBIX

NBIXNeurocrine Biosciences, Inc.$ --
Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

NBIX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
815M USD
YoY +42.2%
Operating Income
193M USD
YoY +719.5%
Net Income
198M USD
YoY +2405.1%
EPS
1.97$
YoY +2362.5%

Revenue

$814.5M
FY2024 Q2$1.1B
$1.1B
Q2
FY2024 Q3$1.7B
$1.7B
Q3
FY2024 Q4$2.4B
$2.4B
Q4
FY2025 Q1$572.6M
$572.6M
Q1
FY2025 Q2$1.3B
$1.3B
Q2
FY2025 Q3$2.1B
$2.1B
Q3
FY2025 Q4$2.9B
$2.9B
Q4
FY2026 Q1$814.5M
$814.5M
Q1
Actual
+$241.9M (+42.2%)

Net Income

$197.9M
FY2024 Q2$108.4M
$108.4M
Q2
FY2024 Q3$238.2M
$238.2M
Q3
FY2024 Q4$341.3M
$341.3M
Q4
FY2025 Q1$7.9M
$7.9M
Q1
FY2025 Q2$115.4M
$115.4M
Q2
FY2025 Q3$324.9M
$324.9M
Q3
FY2025 Q4$478.6M
$478.6M
Q4
FY2026 Q1$197.9M
$197.9M
Q1
Actual
+$190M (+2405.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$1B
Est:$1.1B
FY2020MISS
$1B
FY2021MISS
Actual:$1.1B
Est:$1.1B
FY2021MISS
$1.1B
FY2022BEAT
Actual:$1.5B
Est:$1.5B
FY2022BEAT
$1.5B
FY2023MISS
Actual:$1.9B
Est:$2.1B
FY2023MISS
$1.9B
FY2024MISS
Actual:$2.4B
Est:$2.4B
FY2024MISS
$2.4B
FY2025BEAT
Actual:$2.9B
Est:$2.8B
FY2025BEAT
$2.9B

Analyst Estimates